Specialized Working Group on Infections in Hematology
Overview
The Infections in Hematology SWG drives progress in hematology by ensuring that knowledge is successfully shared, distributed, and accessible to all relevant parties within the community.
We’re focused on:
- Developing and sharing clinically useful tools
- Facilitating access to guidance documents
- Reinforcing networking opportunities for those who manage infections in adult and pediatric hematology
- Enabling access to clinical trial opportunities and connecting clinician researchers to trial sponsors
Open registries
EPICOVIDEHA / EPIRESEHA
What’s it about?
Viral respiratory infections in patients with hematological malignancies.
Include
– Adults (≥18 years)
– With any hematological malignancy (within 5 years)
– Diagnosed with COVID-19, RSV, influenza, hMPV, or any respiratory viral infection
– Confirmed by PCR or antigen test
– Diagnosis from January 2023 onwards
– Both inpatients and outpatients
EPIAMLINF
What’s it about?
All types of infections in patients with acute myeloid leukemia (AML)
Include
– Adults (≥18 years)
– AML original diagnosis from March 2025 onwards
– Newly diagnosed, relapsed, or refractory AML
– Infection occurred within 46 days of AML diagnosis or a new treatment strategy
– Both inpatients and outpatients
Important
– Register separate forms for each treatment phase (e.g., induction, consolidation, relapse)
– Please register all patients, even if they do not experience any infection (the denominator is essential!)
– Don’t stop at induction! Please fill out a new form for each treatment phase (e.g., consolidation, relapse).
– Exclude patients who have undergone a hematopoietic stem cell transplant
HEMASHIELD
What’s it about?
All types of infections in patients treated with bispecific antibodies.
Include
– Adults (≥18 years)
– With any hematologic malignancy
– Treated with bispecific antibodies from March 2025 onwards
– Infection occurred within 365 days of bispecific treatment start
– All infections are eligible: bacterial, viral, fungal, or parasitic
A few important reminders
Volume matters. We truly appreciate your participation, even if only one case is entered—but higher numbers may help improve your authorship position in future publications.
Join us
If you work in our field and share our mission to share knowledge, you’d be welcome to join our SWG. However, before you apply, we recommend you read our application guidance.
Ready? Apply now on the EHA Portal.
Apply to join this SWGIf you have any questions, please email our SWGs team.
Make sure you don’t miss any updates by following us on Twitter/X.